Asia Pacific Point Of Care Drug Of Abuse (doa) Testing Market Size & Outlook
Related Markets
Asia Pacific point of care drug of abuse (doa) testing market highlights
- The Asia Pacific point of care drug of abuse (doa) testing market generated a revenue of USD 189.0 million in 2024.
- The market is expected to grow at a CAGR of 10.4% from 2025 to 2033.
- In terms of segment, immunoassay test strips and cassettes was the largest revenue generating product in 2024.
- Digital/Portable Analyzers is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2033.
Asia Pacific data book summary
| Market revenue in 2024 | USD 189.0 million |
| Market revenue in 2033 | USD 458.1 million |
| Growth rate | 10.4% (CAGR from 2025 to 2033) |
| Largest segment | Immunoassay test strips and cassettes |
| Fastest growing segment | Digital/Portable Analyzers |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Immunoassay Test Strips and Cassettes, Oral Fluid Testing Kits, Breath Analyzers, Urine Collection Cups, Digital/Portable Analyzers |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 17.5% of the global point of care drug of abuse (doa) testing market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 458.1 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Point of Care Drug of Abuse (DOA) Testing Market Scope
Point of Care Drug of Abuse (DOA) Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Premier Biotech | View profile | 51-100 | Minneapolis, Minnesota, United States, North America | https://innovation.premierbiotech.com/ |
| OraSure Technologies Inc | View profile | 638 | 220 East First Street, Bethlehem, PA, United States, 18015 | https://www.orasure.com |
| Draegerwerk AG & Co KGaA | View profile | 16476 | Moislinger Allee 53–55, Lubeck, Germany, 23542 | https://www.draeger.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Quest Diagnostics Inc | View profile | 48000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | https://www.questdiagnostics.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
Asia Pacific point of care drug of abuse (doa) testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point of care drug of abuse (doa) testing market will help companies and investors design strategic landscapes.
Immunoassay test strips and cassettes was the largest segment with a revenue share of 40.11% in 2024. Horizon Databook has segmented the Asia Pacific point of care drug of abuse (doa) testing market based on immunoassay test strips and cassettes, oral fluid testing kits, breath analyzers, urine collection cups, digital/portable analyzers covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Asia Pacific point of care drug of abuse (doa) testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific point of care drug of abuse (doa) testing market databook
-
Our clientele includes a mix of point of care drug of abuse (doa) testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific point of care drug of abuse (doa) testing market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific point of care drug of abuse (doa) testing market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific point of care drug of abuse (doa) testing market size, by country, 2021-2033 (US$M)
Asia Pacific Point of Care Drug of Abuse (DOA) Testing Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
